A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis

Journal of Medical Microbiology

Volumn 49, Issue 3, 2000, Pages 271-278

  Drobniewski, F A ^a   Watterson, S A ^a   Wilson, S M ^a   Harris, G S ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ECONOMIC ASPECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SPUTUM CULTURE; TUBERCULOSIS;

EID: 0034092207     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-3-271     Document Type: Article

References (34)

1. 1. Drobniewski F, Pablos-Mendes A, Raviglione MC. Epidemiology of tuberculosis in the world. Semin Respir Crit Care Med 1997; 18: 419-429.
2. 2. Pablos-Méndez A, Raviglione MC, Laszlo A et al. for the World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug resistance Surveillance. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
3. 3. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
4. 4. Drobniewski FA. Is death inevitable with multi resistant TB plus HIV infection? Lancet 1997; 349: 71-72.
5. 5. Edlin BR, Tokars JI, Grieco MH et al. An outbreak of multi-drug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
6. 6. Small PM, Shafer RW, Hopewell PC et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-1144.
7. 7. Breathnach AS, de Ruiter A, Holdsworth GMC et al. An outbreak of multi-drug resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998; 39: 111-117.
8. 8. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532.
9. 9. Ormerod LP, Charlett A, Gilham C, Darbyshire JH, Watson JM. Geographical distribution of tuberculosis notifications in national surveys of England and Wales in 1988 and 1993: report of the Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1998; 53: 176-181.
10. 10. Irish C, Herbert J, Bennett D et al. Database study of antibiotic resistant tuberculosis in the United Kingdom 1994-6. BMJ 1999; 318: 497-498.
11. 11. Telenti A, Imboden P, Marchesi F et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650.
12. 12. Heym B, Honoré N, Truffot-Pernot C et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994; 344: 293-298.
13. 13. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
14. 14. De Beenhouwer H, Lhiang Z, Jannes G et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995; 76: 425-430.
15. 15. Cooksey RC, Morlock GP, Glickman S, Crawford JT. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997; 35: 1281-1283.
16. 16. Nash KA, Gaytan A, Inderlied CB. Detection of rifampicin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J Infect Dis 1997; 176: 533-536.
17. 17. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-1973.
18. 18. Collins CH, Grange JM, Yates MD. Tuberculosis bacteriology: organization and practice, 2nd edn. Oxford, Butterworth-Heinemann. 1997.
19. 19. Heifets LB, Good RC. Current laboratory methods for the diagnosis of tuberculosis. In: Bloom BR (ed) Tuberculosis pathogenesis, protection and control. Washington, DC, ASM Press. 1994: 85-110.
20. 20. Telles MAS, Yates MD. Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a micro-dilution broth minimum inhibitory concentration (MIC) method. Tuber Lung Dis 1994; 75: 286-290.
21. 21. NHS Executive. Tuberculosis control in London - the need for change. A report for the Thames Regional Directors of Public Health. London, NHS ''
22. 22. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536-548.
23. 23. Interdepartmental Working Group on Tuberculosis. UK Guidance on the prevention and control of transmission of HIV-related tuberculosis, drug-resistant, including multiple drug-resistant tuberculosis. London, UK Department of Health. 1998.
24. 24. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain. 1998: 35.
25. 25. Turett GS, Telzak EE, Torian LV et al. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1238-1244.
26. 26. Telzak EE, Sepkowitz K, Alpert P et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995; 333: 907-911.
27. 27. Park MM, Davis AL, Schluger NW, Cohen H, Rom WN. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am J Respir Crit Care Med 1996; 153: 317-324.
28. 28. Drobniewski FA, Watt B, Smith EG et al. A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom. J Clin Pathol 1999; 52: 334-337.
29. 29. Roth A, Schaberg T, Mauch H. Molecular diagnosis of tuberculosis: current clinical validity and future perspectives. Eur Respir J 1997; 10: 1877-1891.
30. 30. Bennedsen J, Thomsen VO, Pfyffer GE et al. Utility of PCR in diagnosing pulmonary tuberculosis. J Clin Microbiol 1996; 34: 1407-1411.
31. 31. The Workshop Report of the American Thoracic Society Workshop. Rapid diagnostic tests for tuberculosis - what is the appropriate use? Am J Respir Crit Care Med 1997; 155: 1804-1814.
32. 32. Drobniewski F. Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis. BMJ 1998; 317: 1263-1264.
33. 33. Noordhoek GT, Kolk AHJ, Bjune G et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 1994; 32: 277-284.
34. 34. Jewell T. United Kingdom - National health under new management. Lancet 1997; 350: 48-50.